Literature DB >> 26754251

Epidemiology of hepatocellular carcinoma (HCC) in hemophilia.

Shrimati Shetty1, Nitika Sharma2, Kanjaksha Ghosh2.   

Abstract

Hepatocellular carcinoma (HCC) is an important cause of increasing mortality in elderly hemophilia population. Majority of the patients treated with virus non-inactivated factor concentrates prepared from large plasma pools prior to 1985 have been found to be infected with hepatitis C virus (HCV), a major risk factor for HCC. A PubMed search of articles published until February 2015 was performed utilizing the keywords hemophilia, malignancy, neoplasm, cancer, mortality, ageing hemophilia, epidemiology, hepatocellular carcinoma and liver cancer and the relevant articles were included. Contradictory reports are available in literature on the incidence of cancers in general in hemophilia population. Almost all the studies where the incidence of HCC or mortality due to HCC have been analyzed in hemophilia population show that a vast majority of these patients are HCV infected. The incidence of HCC though higher in hemophilic population is related to the higher incidence of HCV infection and not due to the hemophilia phenotype.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Hemophilia; Hepatitis C virus; Hepatocellular carcinoma; Incidence; Risk factors

Mesh:

Year:  2015        PMID: 26754251     DOI: 10.1016/j.critrevonc.2015.12.009

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  9 in total

1.  Future of Haemophilia Research in India.

Authors:  Kanjaksha Ghosh; Rinku Shukla
Journal:  Indian J Hematol Blood Transfus       Date:  2017-09-04       Impact factor: 0.900

2.  Future of Haemophilia Research in India.

Authors:  Kanjaksha Ghosh; Rinku Shukla
Journal:  Indian J Hematol Blood Transfus       Date:  2017-08-21       Impact factor: 0.900

3.  Long noncoding RNA MIR4435-2HG promotes hepatocellular carcinoma proliferation and metastasis through the miR-22-3p/YWHAZ axis.

Authors:  Xuanlin Shen; Yuting Ding; Feng Lu; Haitao Yuan; Wenkang Luan
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

4.  Establishment of a framework for assessing mortality in persons with congenital hemophilia A and its application to an adverse event reporting database.

Authors:  Steven W Pipe; Rebecca Kruse-Jarres; Johnny N Mahlangu; Glenn F Pierce; Flora Peyvandi; Peter Kuebler; Christian De Ford; Fabián Sanabria; Richard H Ko; Tiffany Chang; Charles R M Hay
Journal:  J Thromb Haemost       Date:  2021-01       Impact factor: 5.824

5.  Development and Validation of a Prognostic Signature Associated With Tumor Microenvironment Based on Autophagy-Related lncRNA Analysis in Hepatocellular Carcinoma.

Authors:  Yan Deng; Feng Zhang; Zhen-Gang Sun; Shuai Wang
Journal:  Front Med (Lausanne)       Date:  2021-12-14

6.  PRRC2A Promotes Hepatocellular Carcinoma Progression and Associates with Immune Infiltration.

Authors:  Xin Liu; Yize Zhang; Zenghan Wang; Liwen Liu; Guizhen Zhang; Jianhao Li; Zhigang Ren; Zihui Dong; Zujiang Yu
Journal:  J Hepatocell Carcinoma       Date:  2021-12-01

7.  Induction of ROS mediated genomic instability, apoptosis and G0/G1 cell cycle arrest by erbium oxide nanoparticles in human hepatic Hep-G2 cancer cells.

Authors:  Gehan Safwat; Esraa S M Soliman; Hanan R H Mohamed
Journal:  Sci Rep       Date:  2022-09-29       Impact factor: 4.996

8.  Prognostic significance of preoperative systemic inflammatory biomarkers in patients with hepatocellular carcinoma after microwave ablation and establishment of a nomogram.

Authors:  Shuai Wang; Yan Deng; Xiao Yu; Xue-Wen Zhang; Cheng-Long Huo; Zhen-Gang Sun; Hong Chang
Journal:  Sci Rep       Date:  2021-07-05       Impact factor: 4.379

9.  Identification of Candidate Biomarkers in Malignant Ascites from Patients with Hepatocellular Carcinoma by iTRAQ-Based Quantitative Proteomic Analysis.

Authors:  Jinyan Zhang; Rong Liang; Jiazhang Wei; Jiaxiang Ye; Qian He; Jiazhou Ye; Yongqiang Li; Zhihui Liu; Yan Lin
Journal:  Biomed Res Int       Date:  2018-09-23       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.